| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.033 | 0.5 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.14 | 0.5 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |